Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRA | P10827 | 7/20 | 0.41 |
| ▸ | THRB | P10828 | 7/20 | 0.41 |
| ▸ | ACSS2 | Q9NR19 | 5/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | PPARG | P37231 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3137483 | 1.00 | THRA (0.41) | THRATHRBACSS2LMNAHTT | |
| SCHEMBL3142267 | 0.88 | THRA (0.41) | THRATHRBACSS2LMNAHTT | |
| SCHEMBL3141794 | 0.82 | THRA (0.40) | THRATHRBACSS2LMNA | |
| SCHEMBL3131701 | 0.82 | ACSS2 (0.48) | THRATHRBACSS2PPARG | |
| SCHEMBL3140462 | 0.76 | THRA (0.43) | THRATHRB | |
| SCHEMBL3140469 | 0.76 | THRA (0.43) | THRATHRB | |
| SCHEMBL3145777 | 0.73 | THRA (0.51) | THRATHRB | |
| SCHEMBL3141933 | 0.73 | THRA (0.42) | THRATHRB | |
| SCHEMBL3141938 | 0.73 | THRA (0.42) | THRATHRB | |
| SCHEMBL3130577 | 0.72 | ACSS2 (0.40) | THRATHRBACSS2LMNAPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100004271-A1 | HETEROCYCLIC COMPOUNDS AS AGANIST FOR THE THYROID RECEPTOR | KARO BIO AB (SE) | 2010-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100004271-A1 | HETEROCYCLIC COMPOUNDS AS AGANIST FOR THE THYROID RECEPTOR | TSHR, GHSR, TRHR | THRA 4/4885THRB 6/4885ACSS2 519/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.